Search results
The diagnosis of NCPF and EHPVO is chiefly clinical – presentation with features of PHT without any evidence of liver dysfunction. Patency of hepatic and portal veins is needed for the diagnosis of NCPF/IPH, whereas presence of portal cavernoma on doppler ultrasound (USG) is required for EHPVO.
17 wrz 2020 · The aim of this paper is to make an overview on the denominations, diagnostical features and management of porto-sinusoidal vascular disease (PSVD) and chronic portal vein thrombosis (PVT) being the main causes of NCPH in the Western world.
30 gru 2022 · This topic will discuss the etiology of noncirrhotic portal hypertension and two disorders associated with noncirrhotic portal hypertension: schistosomiasis and idiopathic noncirrhotic portal hypertension (INCPH). Other causes of noncirrhotic portal hypertension are discussed elsewhere.
14 lis 2023 · Interventional Radiology and Surgical Treatment Options for Non-Cirrhotic Portal Hypertension. Article 04 November 2023. Porto-Sinusoidal Vascular Disorder. Chapter © 2022. Introduction/Terminology. Portal hypertension (PH) is the most clinically relevant consequence of cirrhosis.
23 sty 2024 · Non-cirrhotic portal hypertension (NCPH) is a broad term, which includes a heterogeneous group of disorders characterized by elevated portal pressure in the absence of cirrhosis. Despite a better understanding, the diagnosis and treatment remains challenging.
17 wrz 2020 · The present paper represents an overview on the denominations, diagnostical features and management of porto-sinusoidal vascular disease (PSVD) and chronic portal vein thrombosis (PVT) that represent the most frequent causes of NCPH in the Western world.
9 gru 2015 · The key approach to management in NCPF and EHPVO is to control acute variceal bleeding and prevent rebleeding (Figure 1). In EHPVO, in addition, splenomegaly and hypersplenism, growth failure, minimal hepatic encephalopathy, and portal biliopathy need attention.
